Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.
Sci Rep
; 7: 45557, 2017 04 03.
Article
em En
| MEDLINE
| ID: mdl-28367990
ABSTRACT
Liver cancer stem cells (LCSCs) have attracted attention because they cause therapeutic resistance in hepatocellular carcinoma (HCC). Understanding the metabolism of LCSCs can be a key to developing therapeutic strategy, but metabolic characteristics have not yet been studied. Here, we systematically analyzed and compared the global metabolic phenotype between LCSCs and non-LCSCs using transcriptome and metabolome data. We also reconstructed genome-scale metabolic models (GEMs) for LCSC and non-LCSC to comparatively examine differences in their metabolism at genome-scale. We demonstrated that LCSCs exhibited an increased proliferation rate through enhancing glycolysis compared with non-LCSCs. We also confirmed that MYC, a central point of regulation in cancer metabolism, was significantly up-regulated in LCSCs compared with non-LCSCs. Moreover, LCSCs tend to have less active fatty acid oxidation. In this study, the metabolic characteristics of LCSCs were identified using integrative systems analysis, and these characteristics could be potential cures for the resistance of liver cancer cells to anticancer treatments.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Análise de Sistemas
/
Células-Tronco Neoplásicas
/
Carcinoma Hepatocelular
/
Metaboloma
/
Transcriptoma
/
Antígeno AC133
/
Neoplasias Hepáticas
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article